My NCBI | Sign In
RSS Settings
  • Search: Miedema Frank[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 70

    1.

    In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow.

    van Gent R, Kater AP, Otto SA, Jaspers A, Borghans JA, Vrisekoop N, Ackermans MA, Ruiter AF, Wittebol S, Eldering E, van Oers MH, Tesselaar K, Kersten MJ, Miedema F.

    Cancer Res. 2008 Dec 15;68(24):10137-44.PMID: 19074880 [PubMed - indexed for MEDLINE]Related articles

    2.

    A brief history of HIV vaccine research: stepping back to the drawing board?

    Miedema F.

    AIDS. 2008 Sep 12;22(14):1699-703. Review.PMID: 18753857 [PubMed - indexed for MEDLINE]Related articles

    3.

    HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.

    Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM.

    AIDS. 2008 Aug 20;22(13):1583-8.PMID: 18670217 [PubMed - indexed for MEDLINE]Related articles

    4.

    Abundance of early functional HIV-specific CD8+ T cells does not predict AIDS-free survival time.

    Schellens IM, Borghans JA, Jansen CA, De Cuyper IM, Geskus RB, van Baarle D, Miedema F.

    PLoS One. 2008 Jul 23;3(7):e2745.PMID: 18648514 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging.

    Vrisekoop N, van Gent R, de Boer AB, Otto SA, Borleffs JC, Steingrover R, Prins JM, Kuijpers TW, Wolfs TF, Geelen SP, Vulto I, Lansdorp P, Tesselaar K, Borghans JA, Miedema F.

    J Immunol. 2008 Jul 15;181(2):1573-81.PMID: 18606713 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Sparse production but preferential incorporation of recently produced naive T cells in the human peripheral pool.

    Vrisekoop N, den Braber I, de Boer AB, Ruiter AF, Ackermans MT, van der Crabben SN, Schrijver EH, Spierenburg G, Sauerwein HP, Hazenberg MD, de Boer RJ, Miedema F, Borghans JA, Tesselaar K.

    Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6115-20. Epub 2008 Apr 17.PMID: 18420820 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Growth hormone resurrects adult human thymus during HIV-1 infection.

    Tesselaar K, Miedema F.

    J Clin Invest. 2008 Mar;118(3):844-7.PMID: 18292816 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.

    Navis M, Schellens IM, van Swieten P, Borghans JA, Miedema F, Kootstra NA, van Baarle D, Schuitemaker H.

    J Infect Dis. 2008 Mar 15;197(6):871-9.PMID: 18279072 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals.

    Vermeulen JN, Prins JM, Bunnik E, Hack CE, Jurriaans S, Miedema F, Lange JM, Schuitemaker H.

    AIDS Res Hum Retroviruses. 2007 Nov;23(11):1348-53.PMID: 18184076 [PubMed - indexed for MEDLINE]Related articles

    10.

    An unanticipated lack of consensus cytotoxic T lymphocyte epitopes in HIV-1 databases: the contribution of prediction programs.

    Schellens IM, Keşmir C, Miedema F, van Baarle D, Borghans JA.

    AIDS. 2008 Jan 2;22(1):33-7.PMID: 18090389 [PubMed - indexed for MEDLINE]Related articles

    11.

    The HIV RNA setpoint theory revisited.

    Geskus RB, Prins M, Hubert JB, Miedema F, Berkhout B, Rouzioux C, Delfraissy JF, Meyer L.

    Retrovirology. 2007 Sep 21;4:65.PMID: 17888148 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.

    Navis M, Schellens I, van Baarle D, Borghans J, van Swieten P, Miedema F, Kootstra N, Schuitemaker H.

    J Immunol. 2007 Sep 1;179(5):3133-43.PMID: 17709528 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Mitochondrial DNA decline in T cells of HIV-1 seroconverters may be dependent on immune activation.

    Casula M, Vrisekoop N, Wit FW, de Baar MP, de Ronde A, Miedema F, Reiss P.

    J Infect Dis. 2007 Aug 1;196(3):371-6. Epub 2007 Jun 15.PMID: 17597451 [PubMed - indexed for MEDLINE]Related articles

    14.

    Shift of CMV-specific CD4+ T-cells to the highly differentiated CD45RO-CD27- phenotype parallels loss of proliferative capacity and precedes progression to HIV-related CMV end-organ disease.

    Bronke C, Jansen CA, Westerlaken GH, De Cuyper IM, Miedema F, Tesselaar K, van Baarle D.

    Clin Immunol. 2007 Aug;124(2):190-9. Epub 2007 Jun 6.PMID: 17556025 [PubMed - indexed for MEDLINE]Related articles

    15.

    Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease.

    Choudhary SK, Vrisekoop N, Jansen CA, Otto SA, Schuitemaker H, Miedema F, Camerini D.

    J Virol. 2007 Aug;81(16):8838-42. Epub 2007 May 30.PMID: 17537849 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    HIV-1 Subtype C gag-specific T-cell responses in relation to human leukocyte antigens in a diverse population of HIV-infected Ethiopians.

    Tsegaye A, Ran L, Wolday D, Petros B, Dorigo W, Piriou E, Messele T, Sanders E, Tilahun T, Eshetu D, Schuitemaker H, Coutinho RA, Miedema F, Borghans J, van Baarle D.

    J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):389-400.PMID: 17417101 [PubMed - indexed for MEDLINE]Related articles

    17.

    CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater.

    Gras L, Kesselring AM, Griffin JT, van Sighem AI, Fraser C, Ghani AC, Miedema F, Reiss P, Lange JM, de Wolf F; ATHENA, Netherlands National Observational Cohort Study.

    J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):183-92.PMID: 17414934 [PubMed - indexed for MEDLINE]Related articles

    18.

    Stable pattern of HIV-1 subtype C Gag-specific T-cell responses coincides with slow rate of CD4 T-cell decline in HIV-infected Ethiopians.

    Tsegaye A, Ran L, Wolday D, Petros B, Nanlohy NM, Meles H, Girma M, Hailu E, Borghans J, Miedema F, van Baarle D.

    AIDS. 2007 Jan 30;21(3):369-72.PMID: 17255746 [PubMed - indexed for MEDLINE]Related articles

    19.

    Tuberculin skin test conversion and reactivity rates among adults with and without human immunodeficiency virus in urban settings in Ethiopia.

    Tegbaru B, Wolday D, Messele T, Legesse M, Mekonnen Y, Miedema F, van Baarle D.

    Clin Vaccine Immunol. 2006 Jul;13(7):784-9.PMID: 16829616 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency.

    Borghans JA, Bredius RG, Hazenberg MD, Roelofs H, Jol-van der Zijde EC, Heidt J, Otto SA, Kuijpers TW, Fibbe WE, Vossen JM, Miedema F, van Tol MJ.

    Blood. 2006 Jul 15;108(2):763-9.PMID: 16822903 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    6 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity